<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/258551-process-for-the-preparation-of-2-azabicyclo-3-3-0-octane-3-carboxylic-acid-derivatives by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 05:12:35 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 258551:PROCESS FOR THE PREPARATION OF 2-AZABICYCLO[3.3.0]OCTANE-3-CARBOXYLIC ACID DERIVATIVES</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PROCESS FOR THE PREPARATION OF 2-AZABICYCLO[3.3.0]OCTANE-3-CARBOXYLIC ACID DERIVATIVES</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention is aimed at a process for the preparation of compounds of the general formula (I) through the hydrogeneration of cyclization of the intermediates of the formula (II).</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>WO 2006/100168	PCT/EP2006/060406<br>
2<br>
•	Starting from cyclopentene via organomercury compounds<br>
(DE 3300316, R. Henning, H. Urbach, Tetrahdron<br>
Letters, 24, 5343-6 (1983)).<br>
•	Starting from bromocyclopentene and serine and<br>
intramolecular cyclization of an intermediate<br>
iodoalanine with Bu3SnH (DE 297620, H. Urbach, R.<br>
Henning, Heteterocycles 28, 957-65 (1989).<br>
•	By hydrogenation of tetrahydrocyclopentapyrrole-2-<br>
carboxylic acid (WO86/00896, US 4,587,258).<br>
•	By 1,3-dipolar cycloaddition of azomethines (L.M.<br>
Harwood, L.C. Kitchen, Tetrahedron Lett., 34, 6603<br>
(1993)).<br>
The presumably preferred process ( (A. Kleemann, J. Engel,<br>
Pharmaceutical Substances, 4th edition, page 1785, Thieme<br>
Verlag Stuttgart, 2001); EP 79022; V. Teetz, R. Geiger, H.<br>
Gaul, Tetrahedron Letters, 25, 4479-82 (1984)) consists in<br>
first preparing methyl 2-acetamino-3-chloropropionate from<br>
serine in a 3-stage reaction sequence (DE 19941062). This<br>
is reacted with pyrrolidinocyclopentene to give methyl<br>
cyclopentanonylacetamidopropionate. With the aid of strong<br>
acids, this is cyclized with cleavage of the acylamide and<br>
ester group to give the bicyclic iminoester. Subsequent<br>
catalytic hydrogenation then yields racemic 2-azabicyclo-<br>
[3.3 .0]-octane-3-carboxylic acid. The reaction sequence is<br>
shown in Scheme 1:<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
3<br><br>
The 2-azabicyclo-[3.3.0]-octane-3-carboxylic acid is formed<br>
mainly in the cis-endo conformation, i.e. mainly a mixture<br>
of the RRR- and SSS-compounds results. For resolution of<br>
racemates, the carboxylic acid is converted to an ester,<br>
preferably the benzyl ester. This is cleaved into the<br>
diastereomerically pure bicycles by salt formation with a<br>
chiral acid. 0,0-diacyltartaric acids (DE 3345355),<br>
optically active N-acyl-amino acids (EP 115345) and<br>
mandelic acid (J. Martens, S. Liibben, Journal f. prakt.<br>
Chemie, 332, 1111 - 1117 (1990)) are described as chiral<br>
acids.<br>
In order to make possible selective removal of the ester<br>
group in the finished active agent Ramipril, the benzyl<br>
ester is employed for the coupling and therefore preferably<br>
also for the resolution of racemates.<br>
In the preferred process (Kleemann Engel, V. Teetz, R.<br>
Geiger, H. Gaul, Tetrahdron Letters, 25, 4479-82 (1984)),<br>
the resolution of racemates of the benzyl ester is carried<br>
out with the aid of N-benzyloxycarbonyl-L-phenylalanine (Z-<br>
L-Phe-OH). The coupling of the SSS-benzyl ester with N-(l-<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
4<br>
(S)-ethoxycarbonyl-3-phenylpropyl)-(S)-alanine (NEPA) and<br>
subsequent removal of the benzyl ester by hydrogenation<br>
finally yields Ramipril (Scheme 2).<br>
Scheme 2:<br><br>
It was the object of the present invention to make<br>
available an improved process compared with the prior art<br>
for the preparation of intermediates of the general formula<br>
(I). In particular, it is important that the process can be<br>
carried out advantageously on the industrial scale and,<br>
seen from the economic as well as ecological point of view,<br>
that it is superior to the processes of the prior art.<br>
The object is achieved according to the claims. Claims 1 to<br>
4 are aimed at a preferred process for the preparation of<br>
compounds of the general formula (I). Claim 4 protects<br>
novel intermediate compounds of the general formula (II).<br>
Claims 5 to 7 comprise a process according to the invention<br>
for the preparation of compounds of the general formula<br>
(II)•<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
5<br>
As a result of hydrogenating in the presence of a catalyst,<br>
in a process for the preparation of compounds of the<br>
general formula (I) or its salts,<br><br>
in which<br>
R1 is H, (C1-C8)-alkyl, (C6-C18)-aryl, (C7-C19) -aralkyl,<br>
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl,<br>
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8) -cycloalkyl- (C1-C8) -alkyl,<br>
a compound of the general formula (II),<br><br>
in which<br>
R1 is formed as indicated above and<br>
R2 is a hydrogenolytically cleavable group, the object set<br>
is achieved exceedingly advantageously, but for that no<br>
less expectedly. As a result of the fact that, in the<br>
compound of the general formula (II), the radical R2 is a<br>
hydrogenolytically cleavable group, the person skilled in<br>
the art obtains in a surprisingly simple manner in one step<br>
compounds of the general formula (I), which can immediately<br>
be employed in the subsequent conventional resolution of<br>
racemates without further double decomposition steps or<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
6<br>
esterifications having to be carried out. It was thus not<br>
foreseeable against the background of the prior art that<br>
the three chemical steps (cleavage of the N-protective<br>
group, cyclization and hydrogenation) can proceed so<br>
advantageously in one process step.<br>
In the context of the breadth of variation of the radicals<br>
indicated above, the person skilled in the art is free to<br>
choose those which, seen from the cost/benefit ratio,<br>
appear particularly advantageous. As the radical R1,<br>
advantageously H or (C1-C8) -alkyl is employed, R2 can<br>
optionally be ring-substituted benzyl. A radical R1 such as<br>
methyl or ethyl is preferred. Benzyl can preferably be<br>
employed as R2.<br>
For the process according to the invention, the person<br>
skilled in the art can use various organic solvents<br>
suitable for him. Advantageous organic solvents are those<br>
which dissolve the products employed to an adequate extent<br>
and otherwise prove inert to the reaction. Preferred<br>
organic solvents are accordingly those selected from the<br>
group consisting of alcohols, such as, for example,<br>
methanol, ethanol, isopropanol, ethers, such as, for<br>
example, disopropyl ether, methyl tert-butyl ether,<br>
dimethoxyethane, THF, aromatics, such as, for example,<br>
toluene, xylene, carboxylic acid esters such as, for<br>
example, ethyl acetate, isopropyl acetate, n-butyl acetate,<br>
secondary amides such as, for example, DMF, NMP. The use of<br>
alcohols which correspond to the radical R1 is very<br>
particularly preferred. Thus ethanol or methanol is highly<br>
preferred as a solvent.<br>
The objective process can be carried out analogously to<br>
expert knowledge. As a catalyst, those catalysts are<br>
preferably employed which are capable of bringing about the<br>
hydrogenation of C=C and C=N double bonds respectively and<br>
the hydrogenolytic cleavage of the radicals indicated<br>
above. Possible catalysts are both heterogeneous and<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
7<br>
homogeneous catalysts, in particular those selected from<br>
the group consisting of palladium, platinum, rhodium,<br>
nickel, cobalt or the catalysts mentioned for this purpose<br>
in Houben-Weyl, Methoden der Organischen Chemie [Methods of<br>
Organic Chemistry], Volume 4/lc, pages 14-480, Thieme<br>
Verlag Stuttgart, 1974.<br>
The hydrogenation is advantageously carried out at a<br>
temperature of 0-100°C, preferably 10-80°C, particularly<br>
preferably at 20-30°C.<br>
The hydrogen pressure can be adjusted during the reaction<br>
according to the values suitable to the person skilled in<br>
the art. The pressure is preferably 1 to 50 bar, preferably<br>
1 to 30 bar, more preferably 1 to 20 bar.<br>
The hydrogenation according to the invention can be carried<br>
out conventionally using elemental hydrogen. It can,<br>
however, also on principle be run in the form of transfer<br>
hydrogenation, according to the manner known to the person<br>
skilled in the art (Houben-Weyl, Methoden der Organischen<br>
Chemie, Volume 4/lc, pages 67-76, Thieme Verlag Stuttgart,<br>
1974).<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
8<br>
The subject of the present invention is likewise a compound<br>
of the general formula (II) or, if R1 = H, its salts<br><br>
in which<br>
R1 is H, (C1-C8)-alkyl, (C6-C18)-aryl, (C7-C19) -aralkyl,<br>
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl,<br>
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8) -cycloalkyl- (C1-C8) -alkyl and<br>
R2 is a hydrogenolytically cleavable group. These compounds<br>
indicated here are advantageous intermediates for the<br>
preparation of the compound of the general formula (I). The<br>
preferred embodiments indicated above for the radicals R1<br>
and R2 analogously apply here.<br>
In a last embodiment, the present invention is concerned<br>
with the preparation of compounds of the general formula<br>
(II). These are prepared advantageously in a process<br>
according to the invention in which compounds of the<br>
general formula (III)<br><br>
in which<br>
R1 and R2 assume the meaning indicated above,<br>
are reacted with enamines of the general formula (IV)<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
9<br><br>
in which<br>
R3 and R4 independently of one another can be (C1-C8) -alkyl,<br>
(C6-C18)-aryl, (C7-C19) -aralkyl, (C1-C8) -alkyl- (C6-C18) -aryl,<br>
(C3-C8) -cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8)-cycloalkyl-(C1-C8)-alkyl or R3 and R4 together form a<br>
(C2-C5)-alkylene bridge optionally containing heteroatoms.<br>
Here too, the preferred embodiments already just mentioned<br>
apply again for the radicals R1 and R2. Preferred<br>
embodiments for the radicals R3 and R4 are those selected<br>
from the group in which the radicals R3 and R4 form a 5- or<br>
6-membered heterocycle with the nitrogen atom. Compounds of<br>
the formula (IV) are very particularly preferred in which<br>
the radicals R3 and R4, together with the nitrogen atom,<br>
are pyrrolidine, piperidine or morpholine.<br>
Advantageously, the process according to the invention<br>
mentioned here is carried out in organic solvents. Those<br>
which are preferably suitable are: ethers, such as, for<br>
example, disopropyl ether, methyl tert-butyl ether,<br>
dimethoxyethane, THF, aromatics, such as, for example,<br>
toluene, xylene, carboxylic acid esters such as, for<br>
example, ethyl acetate, isopropyl acetate, n-butyl acetate,<br>
secondary amides such as, for example, DMF, NMP,<br>
chlorinated hydrocarbons such as chloroform, methylene<br>
chloride. Halogenated organic solvents are very<br>
particularly preferred in this connection. Chloroform or<br>
methylene chloride is highly preferably employed.<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
10<br>
The reaction of the compounds of the general formula (IV)<br>
with the compounds of the general formula (III) can<br>
preferably be carried out at temperatures between 0-100°C,<br>
preferably 10-50°C, very particularly preferably between<br>
15-30°C.<br>
According to the invention, in the preparation of the<br>
compounds of the general formula (I) the procedure is as<br>
follows. In analogy to N-acyl derivatives (M. Bergmann, K.<br>
Grafe, Hoppe-Seylers Zeitschrift Physiologische Chem. 187,<br>
187 (1930)), the urethanes of the formula (III) can be<br>
prepared from the simply accessible compounds of the<br>
formula (V)<br><br>
and the likewise simply accessible urethanes of the formula<br>
(VI) <br>
For the radicals R1 and R2, the definitions indicated above<br>
consequently apply. The use of ethyl pyruvate and benzyl-<br>
urethane is highly preferred in this connection. The<br>
reaction is preferably carried out in such a way that the<br>
resulting water of reaction is removed by azeotropic<br>
distillation. A particularly suitable solvent for this is<br>
toluene. The person skilled in the art, however, knows<br>
further suitable solvents for this case.<br>
The compounds of the formula (III) can be obtained without<br>
further purification in a purity sufficient for the<br>
subsequent reactions. In order to avoid unintentional<br>
polymerization of the acrylic acid derivatives of the<br>
formula (III), free radical scavengers, preferably<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
11<br>
hydroquinones, are added. The compounds of the general<br>
formula (III) can subsequently be added to compounds of the<br>
general formula (II) as described in a Michael reaction to<br>
give compounds of the general formula (IV). In the<br>
subsequent hydrogenation, the N-protective group is cleaved<br>
and the compound cyclized to give (I).<br>
In contrast to the process described in EP 79022, the<br>
addition of strong acids is not necessary for the reaction.<br>
The cleavage of the N-protective group is carried out in<br>
situ in the process according to the invention by catalytic<br>
hydrogenation. The intermediates of the formula (II)<br>
resulting thereby, which are very unstable in free form, in<br>
which R2 is H, cyclize spontaneously. Use of strong acids,<br>
as required according to the prior art (EP 7 9022), is not<br>
necessary.<br>
A further advantage of the process according to the<br>
invention consists in the fact that the products of the<br>
formula (I), in which R1 is not H, do not have to be<br>
subjected directly to resolution of racemates with<br>
optically active acids such as, for example, N-<br>
benzyloxycarbonyl-L-phenyl-alanine, as the ester group is<br>
retained. Fresh esterifi-cation, as described in EP 79022,<br>
is unnecessary. If the hydrogenation is moreover carried<br>
out without addition of acids, the esters of the formula<br>
(I) are obtained as free bases and can be reacted directly<br>
with optically active acids without further purification.<br>
The diastereomerically pure salts thus obtained of the 2-<br>
azabicyclo-[3.3.0]-octane-3-carboxylic acids prepared<br>
according to this invention can be resolved into their<br>
components in a known manner. The enantiomerically enriched<br>
2-azabicyclo-[3.3.0]-octane-3-carboxylic acid esters<br>
thereby obtained can be converted to the corresponding free<br>
acid by acidic hydrolysis. The release is preferably<br>
carried out such that the (S)-cis-endo-2-azabicyclo-<br>
[3.3.0]-octane-3-carboxylic acid ester is dissolved in<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
12<br>
water at acidic pH and the optically active auxiliary acid<br>
obtained is extracted with an organic solvent and recycled.<br>
The ester can then be cleaved by heating the acidic aqueous<br>
solution. The 2-azabicyclo-[3.3.0]-octane-3-carboxylic acid<br>
can preferably be isolated as an internal salt, but<br>
preferably as the hydrochloride, by evaporating the<br>
reaction solution. The (S)-cis-endo-2-azabicyclo-[3.3.0] -<br>
octane-3-carboxylic acid can be reacted according to known<br>
methods (see above) with N-(1-(S)-ethoxycarbonyl-3-<br>
phenylpropoyl)-(S)-alanine (NEPA) to give Ramipril®.<br>
The objective process thus helps to considerably simplify<br>
the synthesis of the bioactive agent Ramipril for the<br>
industrial scale. This simplification was not automatically<br>
to be expected against the background of the prior art, on<br>
the contrary the intermediates formed during the reaction<br>
are very reactive intermediate compounds which are capable<br>
of entering into many side reactions, such as, for example,<br>
polymerization. Consequently, it can surprisingly be true<br>
that, in spite of this danger, the described combination of<br>
three chemical reaction steps in one process step is<br>
possible.<br>
(C1-C8) -Alkyl radicals are to be regarded as methyl, ethyl,<br>
n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-<br>
butyl, pentyl, hexyl, heptyl or octyl along with all of<br>
their bonding isomers.<br>
The radical (C1-C8)-alkoxy corresponds to the radical (C1-<br>
C8)-alkyl with the proviso that this is bonded to the<br>
molecule via an oxygen atom.<br>
(C2-C8)-alkoxyalkyl are intended as radicals in which the<br>
alkyl chain is interrupted by at least one oxygen function,<br>
it not being possible for two oxygen atoms to be bonded to<br>
one another. The number of carbon atoms indicates the total<br>
number of carbon atoms contained in the radical.<br>
A (C3-C5)-alkylene bridge is a carbon chain with three to<br>
five C atoms, this chain being bonded to the molecule<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
13<br>
considered via two different C atoms.<br>
The radicals described in the preceding paragraphs can be<br>
mono- or polysubstituted by halogens and/or N, 0, P, S, Si<br>
atom-containing radicals. These are, in particular, alkyl<br>
radicals of the abovementioned type, which contain one or<br>
more of these heteroatoms in their chain or which are<br>
bonded to the molecule via one of these heteroatoms.<br>
(C3-C8)-Cycloalkyl is understood as meaning cyclopropyl,<br>
cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl radicals<br>
etc. These can be substituted by one or more halogens<br>
and/or N, O, P, S, Si atom-containing radicals and/or<br>
contain N, O, P, S atoms in the ring, such as, for example,<br>
1-, 2-, 3-, 4-piperidyl, 1-, 2-, 3-pyrrolidinyl, 2-, 3-<br>
tetrahydrofuryl, 2-, 3-, 4-morpholinyl.<br>
A (C3-C8)-cycloalkyl-(C1-C8)-alkyl radical is a cycloalkyl<br>
radical such as shown above, which is bonded to the<br>
molecule via an alkyl radical such as indicated above.<br>
(C1-C8)-Acyloxy is, in the context of the invention, an<br>
alkyl radical such as defined above having at most 8 C<br>
atoms, which is bonded to the molecule via a COO- function.<br>
(C1-C8)-Acyl is, in the context of the invention, an alkyl<br>
radical such as defined above having at most 8 C atoms,<br>
which is bonded to the molecule via a CO- function.<br>
A (C6-C18)-aryl radical is understood as meaning an aromatic<br>
radical having 6 to 18 C atoms. In particular, included in<br>
this are compounds such as phenyl, naphthyl, anthryl,<br>
phenanthryl or biphenyl radicals or systems of the pre-<br>
described type fused to the molecule concerned, such as,<br>
for example, indenyl systems, which can optionally be<br>
substituted by halogen, (C1-C8) -alkyl, (C1-C8) -alkoxy, NH2,<br>
NH(C1-C8) -alkyl, N ((C1-C8)-alkyl)2, OH, CF3, NH (C1-C8)-acyl,<br>
N( (C1-C8)-acyl)2 , (C1-C8)-acyl, (C1-C8)-acyloxy.<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
14<br>
A (C7-C19)-aralkyl radical is a (C6-C18) -aryl radical bonded<br>
to the molecule via a (C1-C8)-alkyl radical.<br>
A (C3-C18)-heteroaryl radical is, in the context of the<br>
invention, a five-, six- or seven-membered aromatic ring<br>
system of 3 to 18 C atoms, which contains heteroatoms such<br>
as, for example, nitrogen, oxygen or sulphur in the ring.<br>
Such heteroatoms are in particular regarded as being<br>
radicals such as 1-, 2-, 3-furyl, 1-, 2-, 3-pyrrolyl, 1-,<br>
2-, 3-thienyl, 2-, 3-, 4-pyridyl, 2-, 3-, 4-, 5-, 6-,<br>
7-indolyl, 3-, 4-, 5-pyrazolyl, 2-, 4-, 5-imidazolyl,<br>
acridinyl, quinolinyl, phenanthridinyl, 2-, 4-, 5-,<br>
6-pyrimidinyl. This radical can be substituted by the same<br>
radicals as as the abovementioned aryl radical.<br>
A (C4-C19)-heteroaralkyl is understood as meaning a hetero-<br>
aromatic system corresponding to the (C7-C19) -aralkyl<br>
radical.<br>
Suitable halogens (Hal) are fluorine, chlorine, bromine and<br>
iodine.<br>
N-Protective groups are to be understood as meaning<br>
protective groups which generally are customarily employed<br>
in amino acid chemistry for the protection of nitrogen<br>
atoms. Those which may particularly be mentioned are:<br>
formyl, acetyl, Moc, Eoc, phthalyl, Boc, Alloc, Z, Fmoc,<br>
etc.<br>
A hydrogenolytically cleavable group is preferably such an<br>
N-protective group selected from the group consisting of<br>
optionally ring-substituted benzyl. Suitable ring-<br>
substituted variants are preferably 4-substituted halogen,<br>
nitro, alkyl or alkoxy derivatives (Houben-Weyl, Methoden<br>
der Organischen Chemie, Volume 15/1, page 69, Thieme Verlag<br>
Stuttgart, 1974).<br>
The term enantiomerically enriched or enantiomeric excess<br>
is understood in the context of the invention as meaning<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
15<br>
the proportion of an enantiomer in the mixture with its<br>
optical antipodes in a range of &gt;50% and 
value is calculated as follows:<br>
([enantiomerl]-[enantiomer2])/([enantiomerl]+[enantiomer2])=ee value<br>
The naming of the	chemical compounds appearing in the text<br>
comprises, in the	context of the invention, all possible<br>
diastereomers, it	also being intended to name the two<br>
optical antipodes	of a respective diastereomer.<br>
The references mentioned in this specification are regarded<br>
as being comprised in the disclosure.<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
16<br>
Examples:<br>
Ethyl N-benzyloxycarbonyl-2-aminoacrylate<br>
288 g of ethyl pyruvate, 250 g of benzylurethane, 2.5 g of<br>
p-toluenesulphonic acid and 1 g of hydroquinone are<br>
introduced into 2.5 1 of toluene and refluxed for 9 h in a<br>
water separator. The reaction solution is then filtered<br>
through silica gel and washed with 500 ml of toluene. The<br>
filtrate is treated with 1 g of hydroquinone and<br>
concentrated to the greatest possible extent on a rotary<br>
evaporator. 37 6 g of ethyl N-benzyloxycarbonyl-2-amino-<br>
acrylate are obtained as an oil, which according to HPLC<br>
has a purity of about 90%.<br>
1H-NMR (DMSO-D6) :1.23 (t, 3H) , 4.18 (q, 2H) , 5.11 (s, 2H),<br>
5.61 (s, 1H), 5.78 (s, 1H), 7.37 (m, 5H), 8.86 (s, 1H).<br>
Ethyl 2-N-benzyloxycarbonylamino-3-(2-oxocyclopentyl)-<br>
propionate<br>
366 g of ethyl N-benzyloxycarbonyl-2-aminoacrylate (about<br>
90% strength) and 191 g of cyclopentenopyrrolidine are<br>
dissolved in CH2Cl2 and the solution is stirred for<br>
16 hours at room temperature. The reaction solution is<br>
subsequently treated with 350 ml of acetic acid and 11 of<br>
water and intensively stirred for 15 min. After phase<br>
separation, the organic phase is again extracted with a<br>
mixture of 180 ml of acetic acid and 1 1 of water and<br>
subsequently washed with 500 ml of water. The solution is<br>
then filtered through silica gel and subsequently<br>
completely evaporated in vacuo. 4 63 g of ethyl 2-N-<br>
benzyloxycarbonylamino-3-(2-oxocyclopentyl)propionate are<br>
obtained as an oil.<br>
1H-NMR (DMSO-D6): 1.17 (m, 3H) , 1.51 (m, 2H) , 1.69 (m, 1H) ,<br>
1.90 (m, 1H), 2.09 (m, 5H), 4.09 (m, 2H), 4.24 (m, 1H, main<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
17<br>
rotamer), 5.05 (s, 2H, main rotamer), 7.34 (m, 5H), 7.75<br>
(d, 1H, main rotamer).<br>
Ethyl cis-2-azabicyclo-[3.3.0]-octane-3-carboxylate<br>
200 g of ethyl 2-N-benzyloxycarbonylamino-3-(2-oxocyclo-<br>
pentyl)propionate is dissolved in 1000 ml of ethanol,<br>
treated with 5 g of catalyst (5% palladium on activated<br>
carbon) and subsequently hydrogenated at 5 bar. After<br>
4 hours, starting material is no longer detectable by HPLC.<br>
The catalyst is filtered and the filtrate is concentrated<br>
to the greatest possible extent. 103 g of ethyl cis-2-aza-<br>
bicyclo-[3.3.0]-octane-3-carboxylate are obtained as a<br>
yellowish-coloured oil, which is reacted further without<br>
further purification. According to the 1H-NMR spectrum, the<br>
proportion of cis-endo isomer is 78 mol%.<br>
1H-NMR (DMSO-D6, main isomer) :1.18 (t, 3H) , 1.30 (m, 1H) ,<br>
1.51 (m, 6H), 2.19 (m, 1H), 2.48 (m, 1H), 3.50 (dd, 1H),<br>
3.53 (m, 1H), 4.07 (dq, 2H).<br>
Ethyl (S)-cis-endo-2-azabicyclo-[3.3.0]-octane-3-<br>
carboxylate Z-L-phenylalanine salt<br>
100 g of the ethyl cis-2-azabicyclo-[3.3.0]-octane-3-<br>
carboxylate prepared in Example 3 are treated with a<br>
solution of 84 g of N-benzyloxycarbonyl-L-phenylalanine in<br>
200 ml of ethyl acetate which is prepared hot. 11 of MTBE<br>
is added to the clear solution. After seeding, it is<br>
stirred for 4 hours at room temperature, the suspension<br>
becoming viscous.<br>
The product is filtered off and washed twice with 100 ml of<br>
MTBE. After drying at 50°C in vacuo, 66.4 g of ethyl (S)-<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
18<br>
cis-endo-2-azabicyclo-[3.3.0]-octane-3-carboxylate Z-L-<br>
phenylalanine salt are obtained.<br>
1H-NMR (DMSO-D6) : 1.18 (t, 3H) , 1.33 (m, 1H) , 1.37 (m, 1H) ,<br>
1.54 (m, 5H), 2.21 (m, 1H), 2.94 (ddd, 2H) , 3.57 (m, 2H) ,<br>
4.08 (dq, 2H), 4.15 (m, 1H), 4.97 (s, 2H), 7.27 (m, 5H),<br>
7.46 (d, 1H).<br>
(S)-cis-endo-2-Azabicyclo-[3.3.0]-octane-3-carboxylic acid<br>
hydrochloride<br>
3.0 g of ethyl (S)-cis-endo-2-azabicyclo-[3.3.0]-octane-3-<br>
carboxylate Z-L-phenylalanine salt are suspended in 20 ml<br>
of water and 40 ml of MTBE. After addition of 1 ml of 37%<br>
strength hydrochloric acid, the mixture is stirred until a<br>
clear solution results. The aqueous phase is separated off<br>
and again extracted with 40 ml of MTBE. It is then briefly<br>
stripped in vacuo, treated with 14 ml of 37% strength<br>
hydrochloric acid and heated for 14 hours at 100 - 105°C.<br>
The mixture is then evaporated in vacuo, and the residue is<br>
treated with 10 ml of acetic acid and evaporated again. The<br>
residue is then dissolved in 10 ml of acetic acid and<br>
crystallized by addition of MTBE. 0.95 g of (S)- cis-endo-<br>
2-azabicyclo- [3.3.0] -octane-3-carboxylic acid hydrochloride<br>
is obtained.<br>
1H-NMR (DMSO-D6) : 1.45 (m, 1H) , 1.60 (m, 3H) , 1.74 (m, 2H) ,<br>
1.99 (m, 1H), 2.45 (m, 1H), 2.80 (m, 1H), 3.98 (m, 1H),<br>
4.21 (dd, 1H), 8.70 (s, broad, 1H), 10.60 (s, broad, 1H),<br>
13.80 (s, broad, 1H).<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
19<br>
Patent claims:<br>
1.	Process for the preparation of compounds of the<br>
general formula (I) or their salts,<br><br>
in which<br>
R1 is H, (C1-C8)-alkyl, (C6-C18) -aryl, (C7-C19) -aralkyl,<br>
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl,<br>
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8) -cycloalkyl- (C1-C8) -alkyl,<br>
characterized in that<br>
a compound of the general formula (II),<br><br>
in which<br>
R1 is formed as indicated above and<br>
R2 is a hydrogenolytically cleavable group,<br>
is hydrogenated in the presence of a catalyst.<br>
2.	Process according to Claim 1,<br>
characterized in that<br>
R1 is H or (C1-C8)-alkyl,<br>
R2 is optionally ring-substituted benzyl.<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
20<br>
3.	Process according to Claim 1 and/or 2,<br>
characterized in that<br>
the hydrogenation is carried out in an alcohol as a<br>
solvent.<br>
4.	Compound of the general formula (II) or, if R1 = H,<br>
its salts<br><br>
in which<br>
R1 is H, (C1-C8)-alkyl, (C6-C18) -aryl, (C7-C19) -aralkyl,<br>
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl ,<br>
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8) -cycloalkyl- (C1-C8) -alkyl and<br>
R2 is a hydrogenolytically cleavable group.<br>
5.	Process for the preparation of compounds according to<br>
Claim 4,<br>
characterized in that<br>
compounds of the general formula (III)<br><br>
in which<br>
R1 and R2 assume the meaning indicated in Claim 4,<br>
are reacted with enamines of the general formula (IV)<br><br>
WO 2006/100168	PCT/EP2006/060406<br>
21<br><br>
in which<br>
R3 and R4 independently of one another can be<br>
(C1-C8)-alkyl, (C6-C18)-aryl, (C7-C19) -aralkyl,<br>
(C1-C8) -alkyl- (C6-C18) -aryl, (C3-C8) -cycloalkyl,<br>
(C1-C8) -alkyl- (C3-C8) -cycloalkyl,<br>
(C3-C8)-cycloalkyl-(C1-C6)-alkyl or R3 and R4 together<br>
form a (C2-C5) -alkylene bridge.<br>
6.	Process according to Claim 5,<br>
characterized in that<br>
the reaction is carried out in halogenated organic<br>
solvents.<br>
7.	Process according to Claim 5 and/or 6,<br>
characterized in that<br>
the reaction is carried out at 20-100°C.<br><br>
The present invention is aimed at a process for the preparation of compounds of<br>
the general formula (I) through the hydrogeneration of cyclization of the<br>
intermediates of the formula (II).<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1jbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-correspondence others 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMgMS4yLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-correspondence others 1.2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1kZXNjcmlwdGlvbiBjb21wbGV0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-description complete.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1mb3JtIDIucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1ncGEucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-gpa.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIGV4bSByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-international exm report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHB1YmxpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHNlYXJjaCByZXBvcnQgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-international search report 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHNlYXJjaCByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-international search report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1wY3QgcHJpb3JpdHkgZG9jdW1lbnQgbm90aWZpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-pct priority document notification.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy1wY3QgcmVxdWVzdCBmb3JtLnBkZg==" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-pct request form.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDM0Nzkta29sbnAtMjAwNy10cmFuc2xhdGVkIGNvcHkgb2YgcHJpb3JpdHkgZG9jdW1lbnQucGRm" target="_blank" style="word-wrap:break-word;">03479-kolnp-2007-translated copy of priority document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1BTUFOREVEIENMQUlNUy5wZGY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-AMANDED CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1DT1JSRVNQT05ERU5DRS5QREY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-CORRESPONDENCE.PDF</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1GT1JNLTIucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1GT1JNLTMucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-FORM-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1GT1JNLTUucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-FORM-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgxNi0wNS0yMDEyKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(16-05-2012)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgyMC0wNC0yMDEyKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(20-04-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgyMC0wNC0yMDEyKS1GT1JNLTMucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(20-04-2012)-FORM-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LSgyMC0wNC0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-(20-04-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LWNvcnJlc3BvbmRlbmNlLnBkZg==" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LWZvcm0gMTMuMS5wZGY=" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-form 13.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LWZvcm0gMTMucGRm" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-form 13.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LW90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1rb2xucC0yMDA3LXAuYS5wZGY=" target="_blank" style="word-wrap:break-word;">3479-kolnp-2007-p.a.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LVBFVElUSU9OIFVOREVSIFJVTEUgMTM0LnBkZg==" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-PETITION UNDER RULE 134.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ3OS1LT0xOUC0yMDA3LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">3479-KOLNP-2007-REPLY TO EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QtMDM0Nzkta29sbnAtMjAwNy5qcGc=" target="_blank" style="word-wrap:break-word;">abstract-03479-kolnp-2007.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="258550-active-session-mobility-solution.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="258552-homogentisate-prenyl-transferase-hpt-nucleic-acids-and-polypeptides-and-uses-thereof.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>258551</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3479/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>04/2014</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>24-Jan-2014</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>20-Jan-2014</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>17-Sep-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>EVONIK DEGUSSA GMBH</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>RELLINGHAUSER STRASSE 1-11, 45128 ESSEN, GERMANY</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>KNAUP, GUNTER</td>
											<td>FRIEDHOFSTR. 8, 63486 BRUCHKOBEL</td>
										</tr>
										<tr>
											<td>2</td>
											<td>LATINOVIC, MILAN</td>
											<td>KREUZWEG 10, 63667 NIDDA</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 209/42</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP2006/060406</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2006-03-02</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>10 2005 012 771.1</td>
									<td>2005-03-19</td>
								    <td>Germany</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/258551-process-for-the-preparation-of-2-azabicyclo-3-3-0-octane-3-carboxylic-acid-derivatives by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 05:12:36 GMT -->
</html>
